World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02213211
Date of registration: 07/04/2014
Prospective Registration: No
Primary sponsor: London School of Hygiene and Tropical Medicine
Public title: School-based Programme of Malaria Diagnosis and Treatment in Southern Malawi
Scientific title: Impact of a School-based Programme of Malaria Diagnosis and Treatment on School Attendance in Southern Malawi
Date of first enrolment: April 2014
Target sample size: 3667
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02213211
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Malawi
Contacts
Name:     Don P Mathanga, MBBS
Address: 
Telephone:
Email:
Affiliation:  Malaria Alert Centre, College of Medicine, Malawi
Name:     Katherine E Halliday, PhD
Address: 
Telephone:
Email:
Affiliation:  London School of Hygiene and Tropical Medicine
Name:     Simon J Brooker, DPhil
Address: 
Telephone:
Email:
Affiliation:  London School of Hygiene and Tropical Medicine
Key inclusion & exclusion criteria

Inclusion Criteria:

- Student enrolled at participating schools in standards 2, 4 and 6

- Provision of informed consent from parent or guardian

- Provision of assent by student

Exclusion Criteria:

- Student unwilling to participate in the study

- Student known to have a chronic medical condition, which will affect their school
attendance



Age minimum: 5 Years
Age maximum: 18 Years
Gender: All
Health Condition(s) or Problem(s) studied
Malaria
Intervention(s)
Drug: Artemether lumefantrine
Primary Outcome(s)
School attendance [Time Frame: 1 year]
Secondary Outcome(s)
Anaemia [Time Frame: 1 year]
Child wellbeing [Time Frame: 1 year]
Stakeholder perceptions of LTK intervention [Time Frame: End of intervention period]
Cost effectiveness [Time Frame: 1 year]
Plasmodium falciparum parasitaemia [Time Frame: 1 year]
Secondary ID(s)
6432
1057
QA475
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Save the Children
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history